1 asset in Chemotherapy-Induced Hypertension

Therapeutic assets addressing Chemotherapy-Induced Hypertension, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Sacubitril Valsartan Chemotherapy-Induced Hypertension	Silesian Centre for Heart Diseases	P4	BB (65)